Business · 13/01/2017Updated: 10/17/2026 · 1 min read
FDA Issues Final Guidance on Repackaging of Human Drug Products by Pharmacies and Outsourcing Facilities
Summary
The FDA has released a final guidance outlining the conditions under which it will not take enforcement action for certain violations of the FD&C Act when pharmacies or outsourcing facilities repack certain human drugs.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →